Drug profile · INN
pemafibrate
PARMODIA
pemafibrate (PARMODIA) is a peroxisome proliferator-activated receptor alpha agonist.
PMDA: approved
Patents linked 1
Pipeline programs 1
News articles 0
Drug details — pemafibrate
- Class
- —
- Route
- —
- Patents
- 1
- Programs
- 1
- Data quality
- 0.78
Quick answer
pemafibrate (PARMODIA) is a peroxisome proliferator-activated receptor alpha agonist.
Key facts
INN pemafibrate
Brand PARMODIA
Mechanism Peroxisome proliferator-activated receptor alpha agonist
Target Peroxisome proliferator-activated receptor alpha
Mechanism of action
Peroxisome proliferator-activated receptor alpha agonist
Primary target: Peroxisome proliferator-activated receptor alpha
Approval history
| Authority | Status | Date |
|---|---|---|
| PMDA | approved | — |
Pipeline programs
Related & competitor drugs
Related patents
Frequently asked questions
What is pemafibrate?
pemafibrate (PARMODIA) is a peroxisome proliferator-activated receptor alpha agonist.
What is the brand name for pemafibrate?
PARMODIA is a marketed brand name for pemafibrate. Check FDA Drugs@FDA for the current US label holder and prescribing information.